Manufacturer: Medis International a.s. , Cehia; Dragenopharm Apotheker Puschl GmbH, Germania; Worwag Pharma Operations Sp. z o.o., Polonia; Wörwag Pharma GmbH & Co. KG, Germania
Country: Germania
Therapeutic class: Medicamente de scadere a glucozei din sang, excl. insuline biguanide
A biguanide class medication for the treatment of type 2 diabetes mellitus. Helps reduce blood glucose to normal values.
Indications: Treatment of type 2 diabetes mellitus when diet and physical exercise are insufficient. Used in overweight adults and children over 10 years of age. May be prescribed alone or in combination with other medications an…
Dosage: Adults: initial dose 500-850 mg 2-3 times daily, maximum 3000 mg daily. Children over 10 years: initial dose 500-850 mg once daily, maximum 2000 mg daily. Dose…
Composition: Active substance: metformin hydrochloride 1000 mg (corresponding to 780 mg metformin). Excipients: hypromellose, povidone K 25, magnesium stearate, macrogol 6000, titanium dioxide.
⚕CNAM-compensated medicine▾
Partial compensation
Pentru tratamentul diabetului zaharat
Adults
per packup to 100.80 MDL
Actual compensation88.47 MDL
Patient pays0 MDL
based on lowest price: 88.47 MDL
Max retail price0.81 MDL / per tablet
Per OMS605/133/2022. The cap is per unit (pill/flacon/ml); actual compensation cannot exceed the shelf price. Present the CNAM prescription at checkout.